286
Participants
Start Date
January 1, 2024
Primary Completion Date
January 1, 2026
Study Completion Date
January 1, 2027
Ribociclib
Participants will receive ribociclib (at a dose of 400mg per day for 3 weeks, followed by 1 week off, 4 weeks for 1 cycle) plus physician-selected endocrine therapy (according to standard clinical practice, TAM or AI, with or without OFS).
RECRUITING
Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
The First Affiliated Hospital of Bengbu Medical University
OTHER
Jinhua Central Hospital
OTHER
Taizhou Central Hospital affiliated to Taizhou University
UNKNOWN
Ningbo Medical Center Lihuili Hospital
OTHER_GOV
The Affiliated People's Hospital of Ningbo University
OTHER_GOV
The First Affiliated Hospital of Zhejiang Chinese Medical University
OTHER
First People's Hospital of Hangzhou
OTHER
Taizhou Hospital
OTHER
Affiliated Zhoushan Hospital of Wenzhou Medical University
OTHER
Zhejiang University
OTHER
Sir Run Run Shaw Hospital
OTHER
Women's Hospital School Of Medicine Zhejiang University
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER